RESEARCHARTICLE
Effect of a Brown Rice Based Vegan Diet and
Conventional Diabetic Diet on Glycemic
Control of Patients with Type 2 Diabetes: A
12-Week Randomized Clinical Trial
Yu-MiLee1,Se-AKim2,3,In-KyuLee4,Jung-GukKim4,Keun-GyuPark4,Ji-YunJeong4¤,
Jae-HanJeon4,Ji-YeonShin5,Duk-HeeLee1,2,3*
1 DepartmentofPreventativeMedicine,SchoolofMedicine,KyungpookNationalUniversity,Daegu,Korea,
a11111 2 DepartmentofBiomedicalScience,KyungpookNationalUniversity,Daegu,Korea,3 BK21PlusKNU
BiomedicalConvergenceProgram,DepartmentofBiomedicalScience,KyungpookNationalUniversity,
Daegu,Korea,4 DepartmentofEndocrinology,SchoolofMedicine,KyungpookNationalUniversity,Daegu,
Korea,5 DepartmentofPreventiveMedicine,SchoolofMedicine,EuljiUniversity,Daejeon,Republicof
Korea
¤ Currentaddress:DepartmentofInternalMedicine,SoonchunhyangUniversityGumiHospital,Gumi,
RepublicofKorea
*lee_dh@knu.ac.kr
OPENACCESS
Citation:LeeY-M,KimS-A,LeeI-K,KimJ-G,Park
K-G,JeongJ-Y,etal.(2016)EffectofaBrownRice Abstract
BasedVeganDietandConventionalDiabeticDieton
GlycemicControlofPatientswithType2Diabetes:A
12-WeekRandomizedClinicalTrial.PLoSONE11
Objective
(6):e0155918.doi:10.1371/journal.pone.0155918
Severalinterventionstudieshavesuggestedthatvegetarianorvegandietshaveclinical
Editor:DavidMeyre,McMasterUniversity,CANADA
benefits,particularlyintermsofglycemiccontrol,inpatientswithtype2diabetes(T2D);
Received:January29,2016
however,norandomizedcontrolledtrialhasbeenconductedinAsianswhomorecommonly
Accepted:May5,2016
dependonplant-basedfoods,ascomparedtoWesternpopulations.Here,weaimedto
Published:June2,2016 comparetheeffectofavegandietandconventionaldiabeticdietonglycemiccontrol
Copyright:©2016Leeetal.Thisisanopenaccess amongKoreanindividuals.
articledistributedunderthetermsoftheCreative
CommonsAttributionLicense,whichpermits MaterialsandMethods
unrestricteduse,distribution,andreproductioninany
medium,providedtheoriginalauthorandsourceare ParticipantsdiagnosedwithT2Dwererandomlyassignedtofolloweitheravegandiet
credited. (excludinganimal-basedfoodincludingfish;n=46)oraconventionaldietrecommended
DataAvailabilityStatement:Datacannotbemade bytheKoreanDiabetesAssociation2011(n=47)for12weeks.HbA1clevelsweremea-
publiclyavailableastheauthorsdidnotreceive suredatweeks0,4,and12,andtheprimarystudyendpointwasthechangeinHbA1clev-
consentfromtheparticipantsduringenrollmentfor
elsover12weeks.
thisspecificrequest.Dataareavailableuponrequest
fromthecorrespondingauthoratlee_dh@knu.ac.kr.
Results
Funding:ThisresearchwassupportedbytheKorea
HealthIndustryDevelopmentInstitute,fundedbythe ThemeanHbA1clevelsatweeks0,4,and12were7.7%,7.2%,and7.1%inthevegan
MinistryofHealth&Welfare(A111716-1202- group,and7.4%,7.2%,and7.2%intheconventionalgroup,respectively.Althoughboth
0000100),aswellastheKoreanHealthTechnology
groupsshowedsignificantreductionsinHbA1Clevels,thereductionswerelargerinthe
R&DProject,fundedbytheMinistryofHealthand
vegangroupthanintheconventionalgroup(-0.5%vs.-0.2%;p-for-interaction=0.017).
Welfare,RepublicofKorea(HI13C0715and
HI11C1300). Whenonlyconsideringparticipantswithhighcompliance,thedifferenceinHbA1clevel
PLOSONE|DOI:10.1371/journal.pone.0155918 June2,2016 1/14
GlycemicControlwithaVeganDietinT2D
CompetingInterests:Theauthorshavedeclared reductionbetweenthegroupswasfoundtobelarger(-0.9%vs.-0.3%).Thebeneficial
thatnocompetinginterestsexist. effectofvegandietswasnotedevenafteradjustingforchangesintotalenergyintakeor
waistcircumferenceoverthe12weeks.
Conclusion
BothdietsledtoreductionsinHbA1clevels;however,glycemiccontrolwasbetterwiththe
vegandietthanwiththeconventionaldiet.Thus,thedietaryguidelinesforpatientswithT2D
shouldincludeavegandietforthebettermanagementandtreatment.However,further
studiesareneededtoevaluatethelong-termeffectsofavegandiet,andtoidentifypotential
explanationsoftheunderlyingmechanisms.
TrialRegistration
CRiSKCT0001771
Introduction
Ahealthydietisoneofthecoreelementsinthemanagementoftype2diabetes(T2D),along
withregularexerciseandpharmacotherapy[1].Infact,dietplaysimportantrolesinT2Dpre-
ventionandmanagement,suchasdecreasingtheriskofdiabetesinindividualswithobesity
andpre-diabetesandavoidingtheassociatedcomplications[2];however,thereiscurrentlyno
generaloptimalmealplanordietarypatternforT2Dpatients[3].
Avegetarianorvegandiethasbeensuggestedtobeclinicallybeneficialinthemanagement
ofdiabetes[4,5].Interestingly,arandomizedclinicaltrial(RCT)hassuggestedthatalow-fat
vegandietcanbemoreeffectiveinglycemicandlipidcontrolthanaconventionaldietrecom-
mendedbytheAmericanDiabetesAssociation(ADA)[6].
Thusfar,mostoftheRCTsonvegetarianorvegandietsinT2Dpatientshaveincludedpop-
ulationsfromWesterncountries[5].ComparedtothepopulationsfromWesterncountries,
Asiansmainlyconsumeadietbasedonplantfoodssuchasrice,vegetables,andfreshfruits[7].
Hence,theuseofavegandietinAsianswithT2DmaybemoreeffectivethanthatinWestern
populations.
Inaddition,bothepidemiologicalandexperimentalevidencehassuggestedthatthechronic
exposuretochemicalssuchaspersistentorganicpollutants(POPs)maydisturbglucoseand
lipidmetabolism[8].Asfattyanimalfoods,includingfish,arethemainsourcesofexposureto
POPs[9],theuseofavegandietthatexcludesanyanimalfoodscouldalsobebeneficialin
termsofavoidingPOPexposure.
Inthepresentstudy,weconductedanRCTtodeterminetheeffectofavegandietonglyce-
miccontrolandothercardiovascularriskfactorsinKoreanpatientswithT2D.
MaterialsandMethods
Participants
Participantswererecruitedthroughadvertisementsintheendocrinologyoutpatientclinicof
KyungpookNationalUniversityHospital,Hypertension-DiabetesEducationCenter,and4
publichealthcentersinDaegucityfromMarch2012throughAugust2012.Theinclusioncrite-
riawereasfollows:ageof30–70years;useofhypoglycemicmedicationsfor(cid:1)6months;and
HbA1clevelof6.0–11.0%.Theexclusioncriteriawereasfollows:increaseddoseof
PLOSONE|DOI:10.1371/journal.pone.0155918 June2,2016 2/14
GlycemicControlwithaVeganDietinT2D
hypoglycemicmedicationortheadditionofanewdrugintheregimenduringthelast2
months;currentvegetarianstatus;pregnancy;orseverecomplicationssuchaschronicrenal
failure.
Samplesizeestimation
Consideringthetwo-samplet-testforabetween-groupHbA1cdifference(effectsize)of0.65%,
standarddeviationof1.0,αlevelof0.05foratwo-tailedtest,powerof80%,andalossoffol-
low-uprateof30%,wefoundthat53participantswouldberequiredforeachgroup[10].
Amongthe106participantsenrolledfromApril2012throughAugust2012,53subjectsand53
subjectswerestratifiedaccordingtoacutoffHbA1cvalueof8.0%andrandomlyallocatedto
theconventionalKoreanDiabeticAssociation(KDA)dietgroupandvegandietgroup,respec-
tively,usingstratifiedblockrandomizationwithablocksizeof4.
Intervention
1)Experimentalgroup:vegandiet. Participantswereaskedtofollowavegandietconsist-
ingofwholegrains,vegetables,fruit,andlegumes.Thefollowinginstructionswereprovidedto
thesepatients:1)ingestunpolishedrice(brownrice);2)avoidpolishedrice(whiterice);3)
avoidprocessedfoodmadeofriceflourorwheatflour;4)avoidallanimalfoodproducts(i.e.,
meat,poultry,fish,dailygoods,andeggs);and5)favorlow-glycemicindexfoods(e.g.,legumes,
legumes-basedfoods,greenvegetables,andseaweed).Participantswerecarefullyeducatedon
thefoodstheyshouldconsumeandshouldavoid.Theamountandfrequencyoffoodcon-
sumption,energyintake,andportionsizeswerenotrestrictedoverthe12-weekperiod.
2)Controlgroup:conventionaldiet. Theconventionaldietfollowedthetreatmentguide-
linesfordiabetesrecommendedbytheKDA2011[11].Participantswereaskedto1)restrict
theirindividualizeddailyenergyintakebasedonbodyweight,physicalactivity,needforweight
control,andcompliance;2)totalcalorieintakecomprised50–60%carbohydrate,15–20%pro-
tein(ifrenalfunctionisnormal),<25%fat,<7%saturatedfat,minimaltrans-fatintake,and
(cid:3)200mg/daycholesterol.Adietitianestimatedtheindividualdailyenergyrequirement(stan-
dardbodyweight[kg]×30–35[kcal/kg])whileconsideringmoderatephysicalactivityinthe
participants,andestablishedthefoodexchangelistsbasedontheindividualdailyenergy
requirementsaspertheKDA2011guidelines.Thetypeandamountoffoodwereclassified
into6foodcategories(grains,meat,vegetables,fatsandoils,milk,andfruits)basedonthe
foodexchangelists,andwereprescribedtoallparticipantsintheKDAgroup.Thedailyenergy
requirementanddailyproportionoffoodcategorieswereappropriatelydistributedinto3
mealsandsnacksconsumedbetweenmeals;theparticipants’foodpreferenceswereconsidered.
Theadjustmentofdailyenergyrequirementbasedonweightlossduringthestudyperiodwas
notperformed.
3)Commonprotocolsforbothgroups. Weconductedanopenrandomizedclinicaltrial
withouttheblindingofparticipantsintermsofthenatureoftheirdietaryintervention.Nospe-
cificmealsormenusweregiventotheparticipants,andtheywerefreetoconsumeanyfood
basedontherecommendationsprovided.Oneregistereddietitianprovidednutritionaleduca-
tionandinstructionfor1houratweek0andweek4,whichhelpedparticipantsmakeappro-
priatelyassigneddietplansusingeducationalmaterials.Thefoodconsumptionstatusofeach
participantwascheckedonceaweekbyadietitianviaatelephoneconsultation.Thedietitian
remindedpatientsaboutthedietaryguidelinesandcookingmethodsthatwerepreviously
describedduringdietaryeducation,providedcounselingtoparticipantsandansweredques-
tions,andencouragedthepatientstorecorddailyfoodconsumption.Thedurationofeduca-
tionwassimilarforbothgroups.Noadditionalfunctionalfoodsorvitaminsupplements
PLOSONE|DOI:10.1371/journal.pone.0155918 June2,2016 3/14
GlycemicControlwithaVeganDietinT2D
includingvitaminB12werepermitted.Theparticipantswereaskedtomaintaintheusuallevel
ofphysicalactivity,andtonotmodifytheirexercisehabitsduringtheinterventionperiod.
Participantswereaskedtomaintaintheircurrentmedication,withoutanycontrolofthe
doseortypeofmedicationfor12weeks;however,dosereductionwaspermittedwhenitwas
necessaryaccordingtoaphysician’sjudgment.Theglucoselevelsweremeasuredasapartof
bloodsamplingatbaseline,andduringthefourthandtwelfthweek;mostparticipantsself-
assessedtheirbloodglucoselevelsviafinger-stickglucosemeasurement.Thestudyprotocol
wasreviewedandapprovedbytheinstitutionalreviewboardofKyungpookNationalUniver-
sityHospital(IRBNo:KNUH2012-03-032).Writteninformedconsentwasobtainedfromall
thesubjectsbeforetheywereenrolledinthestudy.Allparticipantsreceivedafinancialincen-
tive(approximatelyUS$125).ThisstudywasregisteredwiththeClinicalResearchInforma-
tionService(CRiS,Korea,https://cris.nih.go.kr;registrationnumber:KCT0001771).
Measurement
Adietitianconducted24-hourdietaryrecallsthroughunannouncedtelephonecallsatotalof
12times(4timespermonth,including3onweekdaysandonceonaweekend).Thedietary
intakeofthesubjectspriortoparticipationinthetrialwasnotassessed.Energyandnutrition
intakewasanalyzedusingacountry-specificfood-nutrientdatabase(Can-Pro4.0professional
version,theKoreanNutritionSociety,Korea,2011).Physicalexaminationandlaboratorymea-
surements,includingbodyweight,height,waistcircumference,andbloodpressure,were
assessedatweek0,4,and12.Venousbloodwascollectedinthemorning,afterfastingfrom
8:00PMonthepreviousnight.Thefastingbloodglucoselevelwasdeterminedusingthehexo-
kinasemethodwiththeADVIA2400analyzer(Siemens,USA).TheHbA1clevelwasdeter-
minedwiththeturbidimetricinhibitionimmunoassayusingCOBASIntegra800(Roche,
Switzerland).Thelevelsoftotalcholesterolandtriglyceridewereanalyzedusingtheenzymatic
assayandthelevelofhigh-densitylipoprotein(HDL)-cholesterolwasanalyzedbyusingthe
selectiveinhibitionmethodwiththeADVIA2400analyzer(Siemens,USA).Theleveloflow-
densitylipoprotein(LDL)-cholesterolwasestimatedusingtheequationoftotalcholesterol—
(triglycerides/5)—HDLcholesterol.
Compliancebasedonself-assesseddailyrecords
Eachparticipantwasrequiredtofilloutadailydietaryrecordformregardingthetypesand
amountoffoodconsumedduringtheinterventionperiod.Compliancewasmeasuredaccord-
ingtoadaily10-pointscaleviaself-assesseddietaryrecording.Inthevegandietgroup,thedie-
titiandeducted1pointwhenevertheconsumptionofmeats,poultry,fish,dailygoods,oreggs
wasenteredintothedailydietaryrecord.IntheKDAdietgroup,thedietitiancheckedthe
typesandamountoffoodrecordedinthedailyfooddiaryanddeducted1pointwhenever
dailyfoodconsumptionhadnotbeenmaintainedaccordingtotheprescribedfoodexchange
lists.Weusedtheaveragevalueofthedailycompliancescoreover0to12weeks,0to4weeks,
and5to12weeks.
Statisticalanalysis
TheprimaryendpointwastheHbA1clevel.Repeated-measuresanalysisofvariance(RM-A-
NOVA)wasusedtoevaluate1)whethertherewasadifferenceinHbA1clevelsbetweenthe
baselineandendpointinbothgroupsand2)whethertheeffectofdietaryinterventionwasdif-
(cid:4)
ferentovertime,includingtheinteractionofthetimeanddietgroup(time dietgroup).The
secondaryendpointswerebodymassindex(BMI),waistcircumference,systolic/diastolic
bloodpressure(SBP/DBP),fastingbloodglucose,LDL-cholesterol,HDL-cholesterol,and
PLOSONE|DOI:10.1371/journal.pone.0155918 June2,2016 4/14
GlycemicControlwithaVeganDietinT2D
triglyceride.Forintention-to-treat(ITT)analysis,weimputedthemissingHbA1clevelsatthe
fourthandtwelfthweeksbyusingtheHbA1clevelatbaselinebythelast-observation-carried-
forwardimputationmethod.Thenumberofmissingdatapointsweretotal26pointson13
withdrawalparticipants.Moreover,theclinicalanddietaryinformationrequiredforadjust-
mentwerealsoimputedwiththemedianvalueofeachvariableamongthe93subjectswith
completedata.AllanalyseswerecalculatedusingSAS9.4(SASInstituteInc.,Cary,NC).Ap-
valueof<0.05wasconsideredstatisticallysignificant.
Results
Demographicandclinicalcharacteristicsatbaseline
Amongthe106randomizedparticipants,6intheconventionalKDAdietgroupand7inthe
vegandietgroupdroppedoutofthestudy;hence,atotalof47and46participantsfinallycom-
pletedthe12-weekinterventionintheconventionalKDAdietgroupandvegandietgroup,
respectively.All13drop-outsubjectsdidnotreceiveanyeducationanddidnotparticipatein
the4-weekand12-weekfollow-upevaluation.Fig1depictstheinclusionandexclusionofthe
participantsinthestudy.
Whencomparingthedemographicandclinicalcharacteristicsatbaselinebetweenthe2
groups,noneofthevariableswerefoundtobesignificantlydifferent(Table1).Moreover,none
oftheparticipantschangedtheirmedicationdoseoverthe12weeks.
Nutrientintakeduringtheinterventionperiod
Theaverageenergyintakeoverthe12weekswas1,496kcal/dayinthevegandietgroupand
1,559kcal/dayintheconventionaldietgroup,andthedifferencewassignificant(p=0.042;
Table2).Theintakeofnutrientsprimarilyfromplant-basedfoods(carbohydrates,vegetable
fat,fiber,beta-carotene,vitaminE,vitaminK,vitaminC,vitaminB6,folate,phosphorus,and
potassium)wassignificantlyhigherinthevegandietgroupthanintheconventionaldiet
group.Theintakeofnutrientsprimarilyfromanimal-basedfoods(animalfat,protein,choles-
terol,totalfattyacid,saturatedfattyacid,mono-unsaturatedfattyacid,vitaminD,vitamin
B12,andiron)weresignificantlyhigherintheconventionaldietgroupthaninthevegandiet
group.Thenutrientintakesatweek1,week4,andweek12aredescribedinS1Table.
Compliancebasedontheself-assesseddailyrecords
Compliance—evaluatedbasedontheself-assesseddietaryrecord—wasbetterintheconven-
tionaldietgroupthaninthevegandietgroup(Table2).Themeancompliancescore(amaxi-
mumof10points)duringtheoverallinterventionperiodwas9.2±1.6and8.2±1.5inthe
conventionaldietgroupandvegandietgroup,respectively(p=0.002).Comparedtotheearly
phaseofthetrial(firsttofourthweek),thecompliancewaslowerduringthelatephaseofthe
trial(fifthtotwelfthweek)inbothgroups.Theproportionofparticipantswithhighcompli-
ance((cid:1)9points)wassignificantlyhigherintheconventionaldietgroup(78.7%)thaninthe
vegangroup(30.4%)(p<0.001).
Primaryendpoint:Glycemiccontrol
TheHbA1clevelsignificantlydecreasedovertimeinbothgroups:-0.5%inthevegandiet
group(p<0.01)and-0.2%intheconventionaldietgroup(p<0.05)(Table3,Fig2A).However,
thechangesintheHbA1clevelfrombaselinetotheendpointweregreaterinthevegandiet
(cid:4)
groupthanintheconventionaldietgroup(p-for-interactionfortime groupinterac-
tion=0.017).Whenanalyseswererestrictedtosubjectswithahighcompliance((cid:1)9points/10
PLOSONE|DOI:10.1371/journal.pone.0155918 June2,2016 5/14
GlycemicControlwithaVeganDietinT2D
Fig1.Enrollmentofparticipantsinthestudy.
doi:10.1371/journal.pone.0155918.g001
points),thedifferenceinHbA1clevelchangesbetweenthe2groupsbecamemoreremarkable:
-0.9%inthevegangroupand-0.3%intheconventionalgroup(p-for-interactionfortime-
(cid:4)
groupinteraction=0.010)(Table3,Fig2B).Thedifferencesremainedsignificantevenafter
adjustingforenergyintakeorwaistcircumference.TheresultsoftheITTanalysisweresimilar
tothoseofsubjectswithcompletedata(S2Table).
Secondaryendpoint:BMI,waistcircumference,bloodpressure,andlipid
control
TheBMIandwaistcircumferencesignificantlyreducedoverthe12-weekperiodonlyinthe
(cid:4)
vegandietgroup(p-for-interactionfortime groupinteraction=0.027forwaistcircumfer-
ence).However,therewerenosignificantdifferencesinthechangesinSBP,DBP,LDL-
PLOSONE|DOI:10.1371/journal.pone.0155918 June2,2016 6/14
GlycemicControlwithaVeganDietinT2D
Table1. Generalandclinicalcharacteristics1)ofstudyparticipantsatbaseline(week0).
Vegandiet ConventionaldietrecommendedbytheKoreanDiabetes
Association
Characteristics n=46 n=47 pvalue2)
Female[n(%)] 40(87.0) 35(74.5) 0.128
Age(years)[range] 57.5±7.7[32– 58.3±7.0[40–69] 0.593
70]
Durationsincediabetesdiagnosis(years) 9.4±8.1 9.4±5.6 0.995
Receivinginsulin[n(%)] 7(15.2) 8(17.0) 0.813
Glargine[n(%)] 6(13.0) 3(6.4)
Premixedinsulin[n(%)] 0(0.0) 2(4.3)
NPH3)[n(%)] 1(2.2) 1(2.1)
Glargine+rapid-actinganalog[n(%)] 0(0.0) 2(4.3)
Receivingmetformin[n(%)] 34(73.9) 36(76.6) 0.764
Receivingsulfonylurea[n(%)] 17(37.0) 21(44.7) 0.449
Receivingotherdiabetesmedications[n(%)] 14(30.4) 19(40.4) 0.314
Receivinghypertensionmedication[n(%)] 18(39.1) 22(46.8) 0.455
Receivinghypercholesterolemiamedication[n 23(50.0) 26(55.3) 0.608
(%)]
Historyofeyeinvolvement[n(%)] 6(13.0) 6(12.8) 0.968
MNSI4)score[median(range)] 0[0–6] 0[0–4] 0.555
Bodymassindex(kg/m2) 23.9±3.4 23.1±2.4 0.191
Waistcircumference(cm) 85.0±9.8 82.3±7.5 0.143
Systolicbloodpressure(mmHg) 125.1±16.1 128.1±19.9 0.425
Diastolicbloodpressure(mmHg) 75.6±10.9 78.1±12.1 0.305
LDL-cholesterol(mg/dL) 92.7±28.5 102.8±39.0 0.155
Triglyceride(mg/dL) 130.3±61.7 147.7±113.8 0.362
HDL-cholesterol(mg/dL) 50.0±12.3 51.2±13.3 0.639
Fastingbloodglucose(mg/dL) 138.4±52.4 126.3±37.7 0.205
HbA1c(%) 7.7±1.3 7.4±1.0 0.268
1)percentage(%)ormean±standarddeviation
2)calculatedfromthechi-squaretestforcategoricalvariablesorStudent'st-testforcontinuousvariables
3)NeutralProtamineHagedorn(anintermediate-actinginsulin)
4)MichiganNeuropathyScreeningInstrument:Ahigherscore(outofamaximumof13points)indicatesagreaternumberofneuropathicsymptoms.
doi:10.1371/journal.pone.0155918.t001
cholesterollevel,andHDL-cholesterollevelinboththegroups.Thetriglyceridelevelstended
toincreaseinthevegandietgroupandtendedtodecreaseintheconventionaldietgroup(p-
(cid:4)
for-interactionfortime groupinteraction=0.053).Whentheanalyseswererestrictedtosub-
jectswithahighcompliance((cid:1)9points/10points),theresultsremainedunchanged(datanot
shown).
Discussion
Inthepresentstudy,weobservedthatbothveganandconventionaldiabeticdietsweresignifi-
cantlyassociatedwithreductionsinHbA1clevels.However,comparedtotheconventional
diet,thevegandietappearedtobemoreeffectiveforglycemiccontrolamongT2Dpatients.In
particular,thevegandietgroupwithahighcomplianceshowedamarkedlydecreasingtrendin
theHbA1clevel.
PLOSONE|DOI:10.1371/journal.pone.0155918 June2,2016 7/14
GlycemicControlwithaVeganDietinT2D
Table2. Meannutrientintakestatusandcomplianceofthestudyparticipantsduringthe12-weekinterventionperiodinvolvingaveganorconven-
tionaldiet.
Vegandiet ConventionaldietrecommendedbytheKoreanDiabetes p-value1)
n=46 Associationn=47
Nutrients
Energy(kcal) 1,496.2±104.8 1,559.7±181.6 0.042
Carbohydrate(g) 268.4±19.7 249.1±35.5 0.002
Fat(g) 31.8±6.3 34.7±7.8 0.054
Animalfat(g) 2.4±1.5 14.1±5.3 <0.001
Vegetablefat(g) 29.5±6.6 20.6±5.4 <0.001
Protein(g) 55.1±5.8 66.1±9.1 <0.001
Animalprotein(g) 6.4±3.7 28.3±8.2 <0.001
Plantprotein(g) 48.7±5.8 37.8±6.1 <0.001
Cholesterol(g) 70.3±57.4 240.7±74.7 <0.001
Totalfattyacid(g) 15.8±5.0 20.8±5.7 <0.001
SFA(g) 3.2±1.5 6.7±2.7 <0.001
MUFA(g) 5.8±2.2 8.7±3.4 <0.001
PUFA(g) 8.1±2.8 7.9±1.8 0.728
Fiber(g) 33.7±4.8 24.9±4.5 <0.001
VitaminA(ugRE) 1,117.1±352.0 1,037.0±356.4 0.278
Beta-carotene(ug) 6,604.0 5,705.3±2,146.4 0.047
±2,155.0
VitaminD(ug) 0.6±0.5 3.4±1.7 <0.001
VitaminE(ug) 19.6±3.9 16.1±3.1 <0.001
VitaminK(ug) 384.0±199.4 265.2±81.8 <0.001
VitaminC(mg) 135.1±33.2 112.2±25.9 <0.001
VitaminB6(mg) 2.1±0.2 1.7±0.4 <0.001
Folate(ug) 611.1±101.9 545.8±92.7 0.002
VitaminB12(ug) 4.1±1.8 8.5±2.7 <0.001
Calcium(mg) 567.3±116.1 540.4±105.4 0.245
Phosphorus(mg) 1,363.8±127.8 1,121.2±192.1 <0.001
Sodium(mg) 5,127.0±897.8 4,782.4±792.4 0.053
Potassium(mg) 3,583.4±492.5 3,101.4±526.6 <0.001
Magnesium(mg) 92.0±21.5 97.1±28.3 0.339
Iron(mg) 13.9±2.3 15.0±2.7 0.046
Zinc(mg) 10.2±1.2 10.3±1.4 0.869
Compliance
Meanscoreduringthe1stto12thweek 8.2±1.5 9.2±1.6 0.002
Meanscoreduringthe1stto4thweek 8.6±1.3 9.5±1.4 0.003
Meanscoreduringthe5thto12thweek 8.0±1.7 9.1±1.7 0.003
Proportionofhighcompliance[n(%)](meanscorefromthe 14(30.4%) 37(78.7%) <0.001
1stto12thweek(cid:1)9)
1)p-valuescalculatedfromthet-testinthecaseofcontinuousvariablesandthechi-squaretestinthecaseofcategoricalvariablesforbetween-group
comparisons
SFA:saturatedfattyacid;MUFA:mono-unsaturatedfattyacid;PUFA:poly-unsaturatedfattyacid
doi:10.1371/journal.pone.0155918.t002
Importantly,thebenefitofthevegandietwasnotedevenafteradjustingforenergyintake
andwaistcircumferenceoverthe12-weekperiodbetweenthe2groups.Atpresent,weightloss
duetoreducedtotalcalorieintakeisconsideredtobethemainmechanismforachievinggood
PLOSONE|DOI:10.1371/journal.pone.0155918 June2,2016 8/14
GlycemicControlwithaVeganDietinT2D
Table3. Clinicaloutcomesofthestudyparticipantsfollowingaveganorconventionaldietatbaseline,andafterthefourthandtwelfthweeks.
Vegandiet Conventionaldiet pvaluefor
recommendedbytheKorean group*time
DiabetesAssociation interaction1)
n=46 n=47
Clinicaloutcome Week0 Week Week Change Week0 Week Week Change
(baseline) 4 12 (Week (baseline) 4 12 (Week
(final) 12-Week0) (final) 12-Week0)
Primaryendpoint
HbA1c(%)(allparticipants) 7.7±1.3 7.2±1.1 7.1±1.3 -0.5±0.8‡ 7.4±1.0 7.2±0.9 7.2±0.9 -0.2±0.7† 0.017(0.037)2)
(0.042)3)
HbA1c(%) 7.5±1.2 7.0±0.9 6.6±0.9 -0.9±0.8‡ 7.4±1.1 7.3±1.0 7.2±1.0 -0.3±0.7† 0.010(0.013)2)
[compliance(cid:1)9.0 (0.011)3)
(n=14invegan,n=37
inKDA)]
Secondaryendpoint
BMI(kg/m2) 23.9±3.4 23.8 23.5 -0.5±0.9‡ 23.1±2.4 23.1 23.0 -0.1±0.6 0.092
±3.4 ±3.4 ±2.3 ±2.4
Waistcircumference(cm) 85.0±9.8 82.8 81.9 -3.1±4.9‡ 82.3±7.5 82.1 81.5 -0.8±4.6 0.027
±9.7 ±9.9 ±7.6 ±7.9
SystolicBP(mmHg) 125.1±16.1 124.4 126.1 1.0±14.9 128.1±19.9 121.9 126.6 -1.5±18.7 0.186
±16.1 ±14.4 ±16.5 ±16.1
DiastolicBP(mmHg) 75.6±10.9 74.5 76.7 1.1±9.0 78.1±12.1 75.2 76.7 -1.4±9.9 0.335
±10.5 ±9.3 ±10.1 ±10.3
Fastingbloodglucose 138.4±52.4 117.3 125.2 -13.2±47.4 126.3±37.7 119.7 126.3 0.0±39.1 0.146
(mg/dL) ±32.1 ±38.0 ±32.7 ±33.0
LDL-cholesterol(mg/dL) 92.7±28.5 89.1 89.9 -2.8±17.8 102.8±39.0 97.8 101.9 -1.0±29.3 0.732
±31.2 ±32.3 ±36.1 ±38.5
Triglyceride(mg/dL) 130.3±61.7 128.7 143.7 13.4±72.8 147.7 141.9 128.8 -18.9±81.9 0.053
±60.3 ±92.4 ±113.8 ±91.9 ±57.9
HDL-cholesterol(mg/dL) 50.0±12.3 49.5 52.2 2.2±8.8 51.2±13.3 50.8 51.7 0.5±8.2 0.459
±11.9 ±14.9 ±13.1 ±13.0
1)pvaluesforthegroup*timeinteractionwerecalculatedviarepeatedmeasuresanalysisofvarianceorMANOVA(Wilks'lambda)
2)pvaluesforthegroup*timeinteractionafteradjustingforthemeanenergyintake(kcal)overthe12-weekperiod
3)pvaluesforthegroup*timeinteractionafteradjustingforwaistcircumferenceat0,4,and12weeks
†p<0.05
‡p<0.01;pvaluesrepresentthevaluesofthepairedt-testthatassessedwhetherthechangesfrombaselinetothefinalweekweresignificantlydifferent
fromzero.
Noneoftheparticipantsrequiredanychangeinmedicationduringtheinterventionperiod
doi:10.1371/journal.pone.0155918.t003
glycemiccontrolinT2Dpatientswithvariousdietinterventions,includingaveganorvegetar-
iandiet[12].However,thecurrentstudysuggeststhatavegandietmayhaveadditionalbene-
fits,otherthanthelowenergyintakeorweightloss.
Consistentwiththefindingsofthecurrentstudy,arecentmeta-analysisincluding6con-
trolledclinicaltrialsconductedprimarilyintheUnitedStatesshowedthatavegetarianor
vegandiethasasignificantglycemiccontroleffectinthemanagementofT2D[5].Inthe
pooledanalysis,vegetariandietswereassociatedwithasignificantdecreaseinHbA1clevels
(-0.39%),ascomparedtoomnivorousdiets.Thisdifferenceappearstobeslightlylargerthan
thatobservedintheoverallsampleinthepresentstudy;infact,thedifferenceinthechangesin
HbA1Clevelsbetweenthevegandietgroup(-0.5%)andconventionaldietgroup(-0.2%)was
approximately-0.3%.
PLOSONE|DOI:10.1371/journal.pone.0155918 June2,2016 9/14
GlycemicControlwithaVeganDietinT2D
PLOSONE|DOI:10.1371/journal.pone.0155918 June2,2016 10/14
GlycemicControlwithaVeganDietinT2D
Fig2.LevelsofHbA1c(mean±SD)atbaselineandat4and12weeksinindividualswithtype2diabetesfollowinga
veganorconventionaldietrecommendedbytheKoreanDiabetesAssociation.(A)Allparticipants.(B)Participants
withmeancompliance(cid:1)9.0/10points.
doi:10.1371/journal.pone.0155918.g002
Thesefindingsappeartofailtosupportourpriorihypothesisthatavegandietwouldbe
moreeffectiveinT2DmanagementamongAsiansthanamongWesternerswhentheabsolute
valueofdecreasedHbA1cbetweenstudieswassimplycompared.However,whenweonly
comparedparticipantswithgoodcompliance,wenotedthattheHbA1Creductionamongthe
vegandietgroupwas0.9%,andthatthedifferencebetweenthe2groupswasdoubled(-0.6%).
Aspreviousclinicaltrialsdidnotreportresultsonlyfromparticipantswithgoodcompliance,
itisstilldifficulttointerpretthisfindingasdirectevidenceforthegreatereffectivenessofa
vegandietinT2DmanagementamongAsiansthanamongWesterners.
Nevertheless,thereductionofHbA1Clevelsobservedinthevegangroupwithgoodcompli-
anceappearedtobelargerthantheeffectsofotherdietaryapproaches,whichwereexamined
inameta-analysisof20RCTsonvariousT2Ddietinterventions;thelargesteffectwas
observedwithaMediterraneandiet(effectsize,-0.47%)[12].InRCTs,lowcompliancecanbe
expectedwithvegandietsasitwouldbedifficultforindividualswithaprioromnivorousdiet
tomaintainavegandietforseveralmonths.However,ourfindingssuggestthat,ifpatientsare
motivatedtomaintainavegandiet,itcanbeeffectiveinthemanagementofT2D.
Thepracticaladvantagesofvegandietsincludetheabsenceofanyrestrictiononcalorie
intake,lackofnecessityforcalculatingfoodportionsizes,andeaseofunderstandingthediet
methods(noconsumptionofanimalfood)[13].Inparticular,comparedtoconventionaldia-
beticdietsthatarefocusedonrestrictingcalorieintakeandportionsize,vegetariandietsare
reportedlyeasiertofollowduringexercise—anotherkeycomponentofT2Dmanagement—
duetothereducedfeelingofhunger[14].Consideringthatbothdietandexerciseare2vital
componentsfortheoptimalmanagementofT2D,suchadvantageswouldbeimportantfor
T2Dpatients.
Inadditiontoimprovedglycemiccontrol,vegetarianorvegandietsmayofferhealthbene-
fitsassociatedwithcardiovascularriskfactorssuchasserumlipidsandbloodpressure,ascom-
paredtoomnivorousdiets[15].Inameta-analysison11RCTs,vegetarianorvegandietswere
foundtohavesignificantloweringeffectsontheconcentrationsofLDL-cholesterolandHDL-
cholesterol,butnoremarkableeffectontheconcentrationoftriglycerides[16].Moreover,ina
meta-analysison7RCTs,thesedietswerefoundtobeeffectiveinreducingSBPandDBP,in
comparisonwithomnivorousdiets[17].However,wedidnotobserveanybenefitonblood
pressureandlipidsinbothdiets.Theeffectofavegandietonthecardiovascularriskfactors
maybebetterevaluatedamongparticipantswithdyslipidemiaorhypertensionthanamong
thosewithT2D.
SimilartootherT2Ddietinterventions,weightloss(particularlythelossofvisceralfat),asa
resultoflowerenergyintake,hasbeenconsideredamainmechanismforimprovedglycemic
controlwithveganorvegetariandiets[13,14,18].However,thebenefitofvegandietsinthe
presentstudycouldnotbefullyexplainedbyweightlossorlowerenergyintake.Otherpoten-
tialmechanismsmayincludethehigherintakeofdietaryfiber[19].Dietaryfibercanlowerthe
glycemicindexofcarbohydratesbyslowingtheabsorptionofglucosefromtheintestine[20].
Inaddition,dietaryfibercanimproveglycemiccontrolbyincreasingbileacidexcretion[21],
andincreasingtheproductionofshort-chainfattyacidsviathebacterialfermentationoffiber
[22].Thereductionofintramyocellularlipidconcentrationsmayrepresentanotherpossible
mechanism[23].
PLOSONE|DOI:10.1371/journal.pone.0155918 June2,2016 11/14
GlycemicControlwithaVeganDietinT2D
AnotherexplanationmayinvolvethereducedexposuretoPOPsbyvegandietsthroughthe
prohibitionofanimalfood.Recently,backgroundexposuretolow-dosePOPshasbeenfound
tobeanimportantriskfactorofdevelopingT2D[8].Furthermore,thesechemicalsareassoci-
atedwithpoorglycemiccontrolamongT2Dpatients[24],andwithanincreasedriskofcardio-
vasculardiseases[25,26],whicharethemostcommoncomplicationsofT2D.Hence,avoiding
animalfoodcontaminatedwithPOPsmayofferadditionalbenefitforT2Dpatients.
Thereareseverallimitationsofthepresentstudy.First,thestudydurationof3months
wouldnotbesufficienttoevaluatethelong-termeffectsofvegandietsonglycemiccontrol.
However,anRCTwithalongdurationwouldcommonlyinvolvechangesinthemedication
forappropriatemedicalmanagement,andhence,theestimationofeffectsizemightbecompli-
cated[6].Hence,a3-monthstudydurationwithoutanychangeinmedicationwouldbesuit-
ablefortheevaluationofdieteffectsamongT2Dpatients.Second,comparedtoprevioustrials
ondietinterventionthatusedamoreintensiveapproach(includingweeklyorbiweeklygroup
meetings),thisstudyusedonlytelephoneconsultations.Thismaybethereasonforthelow
complianceamongourstudysubjects.Third,mostofthestudyparticipantswerewomen,as
menweredifficulttorecruitfordietintervention.Infact,itisknownthattheparticipantsof
clinicaltrialsoninterventionsfordietorbehavioralchangearepredominantlyfemaledueto
thelowparticipationrateofmales[27].Nevertheless,wecouldnotexcludethepossibilitythat
theeffectofvegandietsmaydifferaccordingtothegender.Fourth,itisunclearwhetherthe
improvementinglycemiccontrolthroughvegandietswouldleadtoareductionintherisksof
macro-ormicrovascularcomplicationsofdiabetes,astherearecertainconcernsregardingthe
potentialoflowintakeofsomenutrientsinavegandietthatisnotplannedwell[28].
Conclusion
Theuseofavegandietfor3monthswasfoundtobemoreeffectiveforglycemiccontrol
amongT2Dpatients,ascomparedtoaconventionaldiabetesdietrecommendedbythe
KDA.However,asthecomplianceofthevegandietgroupwaslowerthanthatofthecon-
ventionalgroup,andbecausedietarychoicesareoftenpersonal,itisnotrealistictorecom-
mendvegandietstoallT2Dpatients.Nevertheless,thiseffectivedietapproachcanbe
appliedforT2Dpatientswhoarestronglymotivatedtofollowavegandiet,particularlyin
theAsianpopulation.
SupportingInformation
S1CONSORTChecklist.
(DOC)
S1Protocol.
(DOC)
S1Table.Nutrientintakestatusofthestudyparticipantsfollowingaveganorconventional
dietafterthefirst,fourth,andtwelfthweeks.
(DOCX)
S2Table.Primaryendpoint(HbA1c)amongallrandomizedparticipantsusinganinten-
tion-to-treatanalysis
(DOCX)
S1Text.Trialprotocol(Korean).
(DOC)
PLOSONE|DOI:10.1371/journal.pone.0155918 June2,2016 12/14
GlycemicControlwithaVeganDietinT2D
AuthorContributions
Conceivedanddesignedtheexperiments:DHL.Performedtheexperiments:SAKJYS.Ana-
lyzedthedata:YML.Wrotethepaper:YMLDHL.Reviewedthemanuscriptandcontributed
tothediscussion:IKLKGPJYJJHJJYSJGK.
References
1. EvertAB,BoucherJL,CypressM,DunbarSA,FranzMJ,Mayer-DavisEJ,etal.Nutritiontherapyrec-
ommendationsforthemanagementofadultswithdiabetes.DiabetesCare.2013;36(11):3821–42.
PMID:24107659.doi:10.2337/dc13-2042
2. BantleJP,Wylie-RosettJ,AlbrightAL,ApovianCM,ClarkNG,FranzMJ,etal.Nutritionrecommenda-
tionsandinterventionsfordiabetes:apositionstatementoftheAmericanDiabetesAssociation.Diabe-
tesCare.2008;31Suppl1:S61–78.PMID:18165339.doi:10.2337/dc08-S061
3. CaoY,MaugerDT,PelkmanCL,ZhaoG,TownsendSM,Kris-EthertonPM.Effectsofmoderate(MF)
versuslowerfat(LF)dietsonlipidsandlipoproteins:ameta-analysisofclinicaltrialsinsubjectswith
andwithoutdiabetes.JClinLipidol.2009;3(1):19–32.doi:10.1016/j.jacl.2008.12.008PMID:
21291785.
4. BarnardND,KatcherHI,JenkinsDJ,CohenJ,Turner-McGrievyG.Vegetarianandvegandietsintype
2diabetesmanagement.NutrRev.2009;67(5):255–63.PMID:19386029.doi:10.1111/j.1753-4887.
2009.00198.x
5. YokoyamaY,BarnardND,LevinSM,WatanabeM.Vegetariandietsandglycemiccontrolindiabetes:
asystematicreviewandmeta-analysis.CardiovascDiagnTher.2014;4(5):373–82.doi:10.3978/j.issn.
2223-3652.2014.10.04PMID:25414824;PubMedCentralPMCID:PMC4221319.
6. BarnardND,CohenJ,JenkinsDJ,Turner-McGrievyG,GloedeL,GreenA,etal.Alow-fatvegandiet
andaconventionaldiabetesdietinthetreatmentoftype2diabetes:arandomized,controlled,74-wk
clinicaltrial.AmJClinNutr.2009;89(5):1588S–96S.PMID:19339401.doi:10.3945/ajcn.2009.
26736H
7. WHO.Diet,nutritionandthepreventionofchronicdiseases.WHOTechnicalReportSeries.2003.
8. LeeDH,PortaM,JacobsDRJr,VandenbergLN.Chlorinatedpersistentorganicpollutants,obesity,
andtype2diabetes.EndocrRev.2014;35(4):557–601.doi:10.1210/er.2013-108410.1210/er.9013-
1084PMID:24483949.
9. KellyBC,IkonomouMG,BlairJD,MorinAE,GobasFA.Foodweb-specificbiomagnificationofpersis-
tentorganicpollutants.Science.2007;317(5835):236–9.doi:10.1126/science.1138275PMID:
17626882.
10. BarnardND,CohenJ,JenkinsDJ,Turner-McGrievyG,GloedeL,JasterB,etal.Alow-fatvegandiet
improvesglycemiccontrolandcardiovascularriskfactorsinarandomizedclinicaltrialinindividuals
withtype2diabetes.DiabetesCare.2006;29(8):1777–83.doi:10.2337/dc06-0606PMID:16873779.
11. CommitteeofClinicalPracticeGuidelinesKDA.2011ClinicalPracticeGuidelinesforType2Diabetes
inKorea2011.
12. AjalaO,EnglishP,PinkneyJ.Systematicreviewandmeta-analysisofdifferentdietaryapproachesto
themanagementoftype2diabetes.AmJClinNutr.2013;97(3):505–16.PMID:23364002.doi:10.
3945/ajcn.112.042457
13. BarnardND,ScialliAR,Turner-McGrievyG,LanouAJ,GlassJ.Theeffectsofalow-fat,plant-based
dietaryinterventiononbodyweight,metabolism,andinsulinsensitivity.AmJMed.2005;118(9):991–
7.doi:10.1016/j.amjmed.2005.03.039PMID:16164885.
14. KahleovaH,MatoulekM,MalinskaH,OliyarnikO,KazdovaL,NeskudlaT,etal.Vegetariandiet
improvesinsulinresistanceandoxidativestressmarkersmorethanconventionaldietinsubjectswith
Type2diabetes.DiabetMed.2011;28(5):549–59.doi:10.1111/j.1464-5491.2010.03209.xPMID:
21480966;PubMedCentralPMCID:PMC3427880.
15. LeLT,SabateJ.Beyondmeatless,thehealtheffectsofvegandiets:findingsfromtheAdventist
cohorts.Nutrients.2014;6(6):2131–47.doi:10.3390/nu6062131PMID:24871675;PubMedCentral
PMCID:PMC4073139.
16. WangF,ZhengJ,YangB,JiangJ,FuY,LiD.EffectsofVegetarianDietsonBloodLipids:ASystematic
ReviewandMeta-AnalysisofRandomizedControlledTrials.JAmHeartAssoc.2015;4(10):e002408.
doi:10.1161/JAHA.115.002408PMID:26508743.
17. YokoyamaY,NishimuraK,BarnardND,TakegamiM,WatanabeM,SekikawaA,etal.Vegetarian
dietsandbloodpressure:ameta-analysis.JAMAInternMed.2014;174(4):577–87.doi:10.1001/
jamainternmed.2013.14547PMID:24566947.
PLOSONE|DOI:10.1371/journal.pone.0155918 June2,2016 13/14
GlycemicControlwithaVeganDietinT2D
18. MishraS,XuJ,AgarwalU,GonzalesJ,LevinS,BarnardND.Amulticenterrandomizedcontrolledtrial
ofaplant-basednutritionprogramtoreducebodyweightandcardiovascularriskinthecorporateset-
ting:theGEICOstudy.EurJClinNutr.2013;67(7):718–24.doi:10.1038/ejcn.2013.92PMID:
23695207;PubMedCentralPMCID:PMC3701293.
19. ChandaliaM,GargA,LutjohannD,vonBergmannK,GrundySM,BrinkleyLJ.Beneficialeffectsofhigh
dietaryfiberintakeinpatientswithtype2diabetesmellitus.NEnglJMed.2000;342(19):1392–8.doi:
10.1056/NEJM200005113421903PMID:10805824.
20. LiveseyG,TagamiH.Interventionstolowertheglycemicresponsetocarbohydratefoodswithalow-
viscosityfiber(resistantmaltodextrin):meta-analysisofrandomizedcontrolledtrials.AmJClinNutr.
2009;89(1):114–25.doi:10.3945/ajcn.2008.26842PMID:19126874.
21. StoryJA,KritchevskyD.Bileacidmetabolismandfiber.AmJClinNutr.1978;31(10Suppl):S199–
S202.PMID:707373.
22. DeVadderF,Kovatcheva-DatcharyP,GoncalvesD,VineraJ,ZitounC,DuchamptA,etal.Microbiota-
generatedmetabolitespromotemetabolicbenefitsviagut-brainneuralcircuits.Cell.2014;156(1–
2):84–96.doi:10.1016/j.cell.2013.12.016PMID:24412651.
23. GoffLM,BellJD,SoPW,DornhorstA,FrostGS.Veganismanditsrelationshipwithinsulinresistance
andintramyocellularlipid.EurJClinNutr.2005;59(2):291–8.doi:10.1038/sj.ejcn.1602076PMID:
15523486.
24. LeeDH,JacobsDRJr,SteffesM.Associationoforganochlorinepesticideswithperipheralneuropathy
inpatientswithdiabetesorimpairedfastingglucose.Diabetes.2008;57(11):3108–11.doi:10.2337/
db08-0668PMID:18647952;PubMedCentralPMCID:PMCPMC2570408.
25. LindL,LindPM.Canpersistentorganicpollutantsandplastic-associatedchemicalscausecardiovas-
culardisease?JInternMed.2012;271(6):537–53.doi:10.1111/j.1365-2796.2012.02536.xPMID:
22372998.
26. LeeDH,LindPM,JacobsDRJr,SalihovicS,vanBavelB,LindL.Backgroundexposuretopersistent
organicpollutantspredictsstrokeintheelderly.EnvironInt.2012;47:115–20.doi:10.1016/j.envint.
2012.06.009PMID:22809777.
27. ArtinianNT,FletcherGF,MozaffarianD,Kris-EthertonP,VanHornL,LichtensteinAH,etal.Interven-
tionstopromotephysicalactivityanddietarylifestylechangesforcardiovascularriskfactorreductionin
adults:ascientificstatementfromtheAmericanHeartAssociation.Circulation.2010;122(4):406–41.
doi:10.1161/CIR.0b013e3181e8edf1PMID:20625115.
28. CraigWJ.Healtheffectsofvegandiets.AmJClinNutr.2009;89(5):1627S–33S.doi:10.3945/ajcn.
2009.26736NPMID:19279075.
PLOSONE|DOI:10.1371/journal.pone.0155918 June2,2016 14/14
